New York, Feb. 17, 2022 (GLOBE NEWSWIRE) -- According to the statistics by the United Nations Education, Scientific and Cultural Organization (UNESCO) Institute for Statistics, the gross domestic expenditure on R&D (GERD) as a percentage of GDP, around the globe, touched 1.73% by the end of 2018, up from 1.66% in the year 2013. On the other hand, in the United States, according to the statistics by the Congressional Budget Office (CBO), the pharmaceutical industry in the year 2019 spend USD 83 Billion on research and developments. This amount recorded to be around 10 times higher than what it was spent in the year 1980s.
Kenneth Research has recently added a report on “Global Molecular Robots Market” which includes details of the latest market trends, along with the growth factors and challenges that are associated with the growth of the market during the forecast period, i.e., 2031-2036. The report also contains insights on the key players operating in the market, along with their product portfolio and growth strategies to help them sustain in the competitive market.
Research and advancements in the field of medical science, especially in the development of new drugs in the pharmaceutical industry, has witnessed significant growth over the past few years, backed by the increasing support for medical R&D investment. In other statistics by the CBO, the number of new drugs approved for sale between 2010 and 2019 increased by 60% as compared to the previous decade. This peaked in the year 2018 as 59 new drugs were approved. The industry has also witnessed a surge in the adoption of robotic technology, backed by the growing awareness for robotic pharmacy dispensing, and for the rising concern for the high cost associated with dispensing errors. In one of the statistics by the International Federation of Robotics (IFR), it has been studied that medication errors, which also include dispensing errors, accounted for USD 42 Billion worldwide.
Get a Sample PDF of This Report @ https://www.kennethresearch.com/sample-request-10352284
The global molecular robots market is estimated to garner a revenue of USD 806.0 Million in the year 2031 and further touch USD 1880.2 Million by the end of 2036, by growing with a CAGR of 18.5% during the forecast period. The market is also anticipated to grow on account of the growing advancements in supramolecular chemistry as well as bioinformatics. Additionally, growing drug discovery for numerous genetic disorders is expected to create numerous opportunities for market growth in the coming years.
On the basis of regional analysis, the global molecular robots market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Amongst the market in these regions, the market in North America is anticipated to garner the largest revenue of USD 348.6 Million in the year 2031 and further reach USD 802.8 Million by the end of 2036. Moreover, the market in the Asia Pacific is anticipated to grow with the highest CAGR of 19.3% during the forecast period.
Browse to access In-depth research report on Molecular Robots Market with detailed charts and figures: https://www.kennethresearch.com/report-details/molecular-robots-market/10352284
The study further incorporates Y-O-Y growth, demand & supply and forecast future opportunity in North America (United States, Canada), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of the Middle East and Africa).
The global molecular robots market is segmented by application into drug discovery & delivery, genetic research, and others. Amongst these segments, the drug discovery & delivery segment is anticipated to register the largest revenue of USD 488.0 Million in the year 2031 and further touch a revenue of USD 1130.0 Million by the end of 2036. Moreover, the genetic research segment is anticipated to grow with the highest CAGR of 19.1% during the forecast period.
Enquiry before Buying This Report @ https://www.kennethresearch.com/sample-request-10352284
The global molecular robots market is also segmented on the basis of end-user into pharmaceutical, research institutions, and others. Amongst these, the pharmaceutical segment is anticipated to generate a revenue of USD 438.9 Million in the year 2031. Moreover, by the end of 2036, the segment is projected to garner a revenue of USD 1017.2 Million.
Some of the prominent industry leaders in the global molecular robots market that are included in our report are Zymergen Inc., Imina Technologies SA, Ginkgo Bioworks, JEOL Ltd., Nanorobotics Ltd., Klocke Nanotechnik GmbH, and others. Besides this, some of the research organizations which are working towards the development of molecular robots are The President and Fellows of Harvard College (Harvard University), New Energy and Industrial Technology Development Organization (NEDO), Tokyo Institute of Technology, The University of Manchester, Hokkaido University, Tohoku University, Kansai University, Molecular Robotics, and others.
Browse More Related Report:
Genomics in Cancer Care Market Segmentation by Type (Consumables, Services, and Instruments); by Application (Personalized Medicines, Diagnostics, Drug Discovery & Development, and Others); by Technology {Microarray, Genome Sequencing, Polymerase Chain Reaction (PCR), and Others}; by End Users (Hospitals, Pharmaceuticals & Biotechnology, Research Institutes, and Others)-Global Demand Analysis & Opportunity Outlook 2031
Mesenchymal Stem Cell (MSC) Market Segmentation by Treatment Type (Autologous and Allogeneic); by Product & Service (Cell Sourcing, Culture & Cryopreservation, and Others); by Source of Isolation (Bone Marrow, Cord Blood, Peripheral Blood, Lungs, and Others); by Application (Disease Modelling, Oncology Disorders, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, and Others); by Stem Cells Indication (Cardiovascular Disease, Liver Disease, Cancer, and Others)-Global Demand Analysis & Opportunity Outlook 2031
Orthopedic Implant Market Segmentation by Product (Dental Implant, Spinal Implant, Joint Reconstruction, Orthobiologics and Others); by Type (Knee, Hip, Wrist & Shoulder, Dental, Spine, Ankle, and Others); by Biomaterial (Metallic Biomaterials, Ceramic Biomaterials, Polymers Biomaterials, and Others); by End Users (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others)-Global Demand Analysis & Opportunity Outlook 2031
Global Androgen Deprivation Therapy (ADT) Market Size study, by Drug Class (Antiandrogens, LHRH Agonists, LHRH Antagonist, Others), by Route of Administration (Oral, Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2019-2026
Global Cell Lysis/Cell Fractionation Market Size study, by Product (Consumables, Instruments) By Type of Cell (Mammalian Cells, Microbial Cells, Other Cells) By End User (Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, Others) and Regional Forecasts 2019-2026
About Kenneth Research
Kenneth Research is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates, and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: info@kennethresearch.com
U.S. Phone: +1 313 462 0609
Web: https://www.kennethresearch.com/
